Doravirine Patent Expiration
Doravirine is Used for treating HIV-1 infection in pediatric patients. It was first introduced by Merck Sharp And Dohme Corp A Sub Of Merck And Co Inc
Doravirine Patents
Given below is the list of patents protecting Doravirine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Pifeltro | US8486975 | Non-nucleoside reverse transcriptase inhibitors | Oct 07, 2031 | Msd Merck Co |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳